v3.26.1
SEGMENT INFORMATION - COMPANY’S REPORTABLE SEGMENT INFORMATION (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenue, Major Customer [Line Items]    
Net sales $ 880 $ 879
Operating (loss) income (35) 63
Interest expense, net 24 19
Other income (17) 0
Restructuring and other costs 67 9
Amortization of intangibles 41 45
Income before income taxes (42) 44
Total Depreciation and Amortization 79 79
Operating Segments    
Revenue, Major Customer [Line Items]    
Net sales 880 879
Operating (loss) income 146 205
All Other    
Revenue, Major Customer [Line Items]    
Unallocated corporate costs 72 87
Total Depreciation and Amortization 6 6
Segment Reconciling Items    
Revenue, Major Customer [Line Items]    
Interest expense, net 24 19
Other income (17)  
Goodwill and intangible asset impairments 0  
Restructuring and other costs 67 9
Amortization of intangibles 42 45
Depreciation resulting from the fair value step-up of property, plant, and equipment from business combinations 0 1
Connected Technology Solutions | Operating Segments    
Revenue, Major Customer [Line Items]    
Net sales 246 235
Adjusted cost of products sold 156 135
Adjusted selling expenses 53 57
Adjusted general and administrative (“G&A”) expenses 23 19
Adjusted research and development (“R&D”) expenses 20 17
Operating (loss) income (6) 7
Total Depreciation and Amortization 37 43
Essential Dental Solutions | Operating Segments    
Revenue, Major Customer [Line Items]    
Net sales 350 353
Adjusted cost of products sold 132 124
Adjusted selling expenses 69 71
Adjusted general and administrative (“G&A”) expenses 20 18
Adjusted research and development (“R&D”) expenses 8 5
Operating (loss) income 121 135
Total Depreciation and Amortization 8 9
Orthodontic and Implant Solutions | Operating Segments    
Revenue, Major Customer [Line Items]    
Net sales 199 217
Adjusted cost of products sold 104 93
Adjusted selling expenses 54 54
Adjusted general and administrative (“G&A”) expenses 21 22
Adjusted research and development (“R&D”) expenses 12 11
Operating (loss) income 8 37
Total Depreciation and Amortization 23 19
Wellspect Healthcare | Operating Segments    
Revenue, Major Customer [Line Items]    
Net sales 85 74
Adjusted cost of products sold 37 27
Adjusted selling expenses 14 13
Adjusted general and administrative (“G&A”) expenses 8 6
Adjusted research and development (“R&D”) expenses 3 2
Operating (loss) income 23 26
Total Depreciation and Amortization $ 5 $ 2